How to Respond to a USPTO Office Action: Deadlines, Fees and Your Real Options in 2026

A Rejection Is the Start of a Negotiation

An office action can read like a verdict. It is better treated as the examiner's opening position. What you do next, and how quickly, determines both whether you get a patent and how much that patent is worth later.

Several things have changed recently. A key after-final program has ended, the threshold for reviving an abandoned application dropped in August 2026, and examiners are credited differently for interviews.

The Clock

An office action on the merits normally sets a three-month period for reply (MPEP 710.02(b)). You can buy more time, but never beyond the six-month statutory limit (35 USC 133; 37 CFR 1.136).

These are the extension fees listed on November 6, 2026 (USPTO Fee Schedule):

Extension	Undiscounted	Small entity	Micro entity
1 month	$235	$94	$47
2 months	$690	$276	$138
3 months	$1,590	$636	$318

Longer extensions exist where the set period was shorter. The third month costs nearly seven times the first, so the cheapest plan is to start early. The period runs from the mail or notification date, and a period ending on a weekend or federal holiday moves to the next business day (MPEP 710).

If You Miss the Deadline

An application goes abandoned by operation of law when a timely reply is not filed, not when a notice arrives (USPTO Revival Page). You can petition to revive it, but you must state that the entire delay was unintentional (37 CFR 1.137).

Since August 13, 2026, the stricter tier begins after one year instead of two. Beyond that point the undiscounted fee is $3,000 rather than $2,260, and you must explain the delay (91 FR 37826). Even the lower revival fee costs more than the largest routine extension in the table above, and an inaccurate statement of delay can jeopardize enforcement later. Extensions are the cleaner path while they remain available.

Read the Rejection Before You Write Anything

Each statutory basis calls for a different response:

§ 101 (eligibility): the examiner says the claim is directed to an exception. See our guide to software and AI eligibility.
§ 102 (anticipation): a single reference is said to disclose every element of the claim.
§ 103 (obviousness): the examiner combines references. The analysis follows the Graham factors (Graham v. John Deere), applied flexibly after KSR (KSR v. Teleflex).
§ 112 (disclosure and clarity): the issue is written description, enablement or definiteness.

In our view, simply arguing that the references contain no express motivation to combine is a weak § 103 response after KSR. Unpredictability, no reasonable expectation of success, and objective evidence tend to carry more weight.

Whatever you do, amendments cannot introduce new matter (35 USC 132). Anything you add has to be supported by the application as filed.

Talk to the Examiner

An interview can often settle in an hour what several rounds of paper cannot, although it does not replace the need to file a reply (MPEP 713). Requests now run through Patent Center: the Automated Interview Request form moved there on March 9, 2026 (USPTO Announcement).

Credit has changed too. Examiners now get one hour of interview time per new application or RCE, with additional time needing supervisor approval, while interviews must not be arbitrarily refused (USPTO Examiner PAP Slides). So plan around that hour: use it on the round where it counts, come with a proposed amendment, and give a specific reason if you ask for a second interview.

After a Final Rejection: Your Four Routes

A final rejection narrows your options, but it does not end the application. One old option has gone: the USPTO stopped accepting AFCP 2.0 requests after December 14, 2024 (FR Doc. 2024-22481). We found no replacement, so older advice that relies on it is out of date.

1. A reply under Rule 116. You can cancel claims or fix form issues as of right, and anything touching the merits requires good and sufficient reasons (37 CFR 1.116). There is a timing benefit: file a first reply within two months of a final action that set a three-month period, and if the advisory action arrives after the three months, the period ends on its mailing date, up to the six-month limit (MPEP 706.07(f)).

2. A Request for Continued Examination. An RCE reopens prosecution (37 CFR 1.114). The first costs $1,500 undiscounted and later ones cost $2,860 (USPTO Fee Schedule). Waits may lengthen: cases awaiting action after an RCE rose from 14.6K to 30.5K between August 2025 and August 2026 (USPTO FY2026 Pendency Review).

3. An appeal. A notice of appeal costs $905 undiscounted, and forwarding the appeal to the Board costs $2,535 (USPTO Fee Schedule). A pre-appeal brief conference lets you put up to five pages of argument in front of a review panel (MPEP 1204). Since 2026, a PTAB judge may also join that panel in an advisory role (USPTO Official Gazette Notice).

4. A continuation. File before the first application is patented or abandoned (35 USC 120). This suits cases where you want allowed claims now and broader claims later.

If your situation is...	Consider
A small fix would resolve it	Rule 116 reply, ideally after an interview
You need new claims or evidence considered	RCE
The examiner's position is simply wrong	Pre-appeal conference and appeal
Some claims are allowable and you want more	Continuation

That table is our rule of thumb, not an official standard. The right route depends on your claims and your budget.

Every Word Follows the Patent

Amendments and arguments do not disappear when the patent issues. A narrowing amendment made to satisfy the Patent Act can create an estoppel that limits the doctrine of equivalents, although the bar is not absolute (Festo v. Shoketsu). Arguments can narrow a patent too (Haynes Boone).

So argue only what you need. Do not characterize your invention or the prior art more broadly than the rejection requires, and avoid narrowing a claim further than necessary to overcome it.

What to Expect on Timing

At the close of FY2026, first-action pendency was 20.5 months, short of the USPTO's 20.2-month target, and the unexamined inventory stood at 745,074, down from 788,229 a year earlier (USPTO FY2026 Pendency Review). Every avoidable round of prosecution can add many months, so a focused first response is worth the effort.

The Bottom Line

Diary the deadline the day the action arrives, read each rejection on its own terms, speak to the examiner, and write as if a future opponent will read every sentence, because one might.

Obsidyan's office action tools help you break down rejections, review examiner analytics and prepare a first draft of a response, with deadlines tracked in one place. Have a registered practitioner review any response before it is filed.

Sources

Sources checked November 6, 2026. Fees, pilot programs and pending rules change, so confirm current figures with the USPTO. This article is general information, not legal advice, and Obsidyan is not a law firm. Talk to a registered patent attorney or agent about your situation.